(PharmaNewsWire.Com, March 07, 2018 ) Cells are considered as the basic unit of life. The study of different cell structures is called cell biology. The understanding of cells and their components is crucial as several patterns can be observed and several compounds can be discovered. This could contribute to the discovery of new treatments or advancements of existing treatments. Cell biology can also help increase target population and enhance the mechanism of action (MOA) to reduce treatment time.
Publisher's analysts forecast the global cell lysis market to grow at a CAGR of 7.54% during the period 2017-2021.
Covered in this report The report covers the present scenario and the growth prospects of the global cell lysis market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of instruments and consumables that are used for cell lysis.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Cell Lysis Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Other prominent vendors -Becton, Dickinson and Company -Cell Signaling Technology -F. Hoffmann-La Roche -Miltenyi Biotec -Omni International -Qiagen -Qsonica
Market driver -Expanding biotechnology industry -For a full, detailed list, view our report
Market challenge -Excessive cost of cell-based research -For a full, detailed list, view our report
Market trend -Emergence of unique methods of cell disruption -For a full, detailed list, view our report
Table of Contents
PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: INTRODUCTION PART 05: MARKET LANDSCAPE PART 06: MARKET SIZING PART 07: FIVE FORCES ANALYSIS PART 08: MARKET SEGMENTATION BY PRODUCT PART 09: MARKET SEGMENTATION BY END-USER PART 10: REGIONAL LANDSCAPE PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES PART 13: MARKET TRENDS PART 14: VENDOR LANDSCAPE PART 15: VENDOR ANALYSIS PART 16: APPENDIX
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
